Previous 10 | Next 10 |
home / stock / tdsgf / tdsgf news
Toronto, Ontario--(Newsfile Corp. - March 7, 2022) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ( the "Company" or "TELO") announces that it has received clinical samples from its collaborator, Mayo Clinic, to conduct the clinical validation of the Company's lead product ...
Toronto, Ontario--(Newsfile Corp. - February 3, 2022) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") is pleased to announce that Dr. Ron McGlennen, President and Founder of the medical laboratory Access Genetics, Minnesota, USA, has joined its Board of Directors. Dr. McGlen...
Toronto, Ontario--(Newsfile Corp. - January 19, 2022) - Telo Genomics Corp. (TSXV: TELO) ( the "Company" or "TELO") announces the launch of a validation study to accelerate the commercialization of its lead product in development for smoldering multiple myeloma (SMM) patients. The Company...
Toronto, Ontario--(Newsfile Corp. - December 7, 2021) - Telo Genomics Corp. (TSXV: TELO) ( the "Company" or "TELO") is pleased to announce its successful uplisting from the OTC Pink Sheets to the OTCQB® Venture Market (the "OTCQB"). TELO commenced trading on the OTCQB at market open...
Toronto, Ontario--(Newsfile Corp. - October 13, 2021) - Telo Genomics Corp. (TSXV: TELO) (the " Company " or " TELO ") is pleased to announce updates related to its recent participation in the International Multiple Myeloma Workshop in Vienna, Austria, and progress of the ongoing clinical st...
Toronto, Ontario--(Newsfile Corp. - October 5, 2021) - Telo Genomics Corp. (TSXV: TELO) (the " Company " or " TELO ") is pleased to announces its board of directors (the " Board ") has adopted amendments to its By-Laws (the " Amended By-Laws ") to include advance notice provisions (the " Adv...
Toronto, Ontario--(Newsfile Corp. - September 21, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO" ) is pleased to announce that it has entered into a consulting agreement (the " Consulting Agreement ") with Adelaide Capital Markets Inc. (" Adelaide ") to provide investor r...
Toronto, Ontario--(Newsfile Corp. - September 9, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO" ) is pleased to announce that it is participating in the 18 th International Myeloma Society Workshop 2021 (IMW 2021) taking place in Vienna, Austria between September 8 th ...
Toronto, Ontario--(Newsfile Corp. - August 9, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") is pleased to announce that the Company has entered into an agreement with the clinical laboratory veteran Mark Stene, Founder & President of MyClinLab ® LLC, Aust...
Toronto, Ontario--(Newsfile Corp. - July 2, 2021) - Telo Genomics Corp. (TSXV: TELO) (the " Company " or " TELO ") announces that it has closed the first tranche of its previously announced non-brokered private placement (" Offering ") of units (the " Units "). The Company issued a total o...
News, Short Squeeze, Breakout and More Instantly...
Teledata Singapore Ltd Company Name:
TDSGF Stock Symbol:
OTCMKTS Market:
Teledata Singapore Ltd Website:
Toronto, Ontario--(Newsfile Corp. - June 18, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ( the "Company" or "Telo") a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncolo...
Toronto, Ontario--(Newsfile Corp. - June 12, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3D0A) ("Telo" or the "Company"), is pleased to announce that results of the development, validation and implementation of its machine learning and Artificial Intelligence (AI) modules, u...
Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (FSE: 3DOA), ( the "Company" or "Telo"), a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications in oncology, is thrilled t...